MRI-Derived Abdominal Subcutaneous Fat And Heart Failure Risk

10 Jul 20264 min read0 viewsVerified Feed

GIST (Key Takeaways)

Background: Obesity is a major modifiable risk factor for heart failure (HF), but body mass index (BMI) does not distinguish biologically distinct fat depots. Whether imaging-derived adipose tissue depots capture specific cardiometabolic pathways underlying HF risk beyond conventional anthropometric measures remains uncertain. Methods: We performed two-sample Mendelian randomization (MR) and multivariable MR mediation analyses using published genome-wide association study summary statistics.
General adiposity traits included BMI, waist-to-hip ratio (WHR), and WHR adjusted for BMI from GIANT and UK Biobank meta-analyses of up to 694,649 individuals. MRI-derived visceral adipose tissue (VAT), abdominal subcutaneous adipose tissue (ASAT), and gluteofemoral adipose tissue (GFAT) were derived from 38,965 UK Biobank participants. HF outcome data were obtained from the HERMES consortium, including 1,946,349 individuals and 153,174 HF cases.
Cardiometabolic mediators included type 2 diabetes (T2D), systolic blood pressure (SBP), LDL cholesterol, HDL cholesterol, and triglycerides. Primary analyses used inverse-variance weighted MR, with sensitivity analyses and directionality testing. Mediation was estimated using joint multivariable MR conditioning on significant cardiometabolic mediators.

medRxiv (Clinical Preprints) published a clinical update in Research Highlights on 10 Jul 2026.

The item focuses on MRI-Derived Fat Depots and Cardiometabolic Pathways Underlying Heart Failure Risk: A Mendelian Randomization Study.

Review the original article for the full source wording and details.

Read the full original publication from the source journal or publisher link below.

Feed Metadata

Source

medRxiv (Clinical Preprints)